Eculizumab ( 依库珠单抗 )

产品编号：YR1003；

分子名称：Eculizumab；

克隆性：Monoclonal；

产品别称：5G1.1, h5G1.1HuG2/G4；

关键词：5G1.1, Anti-Human C5 ADCC Therapeutic Antibody, Eculizumab5G1.1, h5G1.1HuG2/G4, Anti-Human C5 ADCC Therapeutic Antibody, Eculizumab, 依库珠单抗；

规格：1mg, 5mg；

浓度：1mg/ml；

抗体亚型：IgG2-G4 Kappa；

宿主：；

CAS号：219685-50-4；

来源：CHO Cells；

纯度：≥95% as determined by SDS-PAGE；

缓冲体系：Supplied in PBS, PH7.5；

分子量：148000.00 Da；

产品背景：Eculizumab, sold under the brand name Soliris among others, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death.；

保存条件：Stored at -20℃ to -80℃.；

运输条件：Shipped on ice packs.；

产品应用：ELISA, FC, IP, FuncS, IF, Neut；